The Texas Racing Commission has authorized the Texas Medical Diagnostic Laboratory to increase the amount of ELISA tests it conducts and decrease the number of screens it evaluates from urine samples collected for post-race analysis.
The Kentucky Equine Drug Research Council met Thursday at Keeneland to discuss options to identify and enforce the prohibited use of erythropoietin (EPO).
The attached list of racing organizations and officials were invited to attend a one-day workshop for the purpose of determining if agreement could be reached as to the need for a uniform policy for racehorse medication in the United States, and if so, where agreement can be reached on elements of such a policy. The workshop consisted of two segments: a two-hour open session briefing by experts on topics pertinent to the purpose of the Summit, and an intensive seven-hour workshop for the invited representatives which was conducted by a professional facilitator from outside the racing industry.
Most Popular Stories
- Downey Profile: Improvement Mandated in Rebel
- Tapiture Takes On Rebel Invaders and Old Foes
- Social Inclusion Spoils Honor Code's Return
- Study Links Cell Damage to Corticosteroids
- Azeri: Don't Tell Sophia Faces Close Hatches
- Steve Haskin's Derby Dozen 3/10/2014
- Iotapa Heads Tough Lineup in Santa Margarita
- Sign Runs Last in Return from Lengthy Layoff
- Hall of Fame Jockeys to Compete at Pimlico
- New Standards May Be Imposed on NY Stewards